Biomedical applications of fermenticin HV6b isolated from lactobacillus fermentum HV6b MTCC10770

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Kaur, Baljinder ^a   Balgir, Praveen P ^a   Mittu, Bharti ^a   Kumar, Balvir ^a   Garg, Neena ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; BACTERIOCIN; CONTRACEPTIVE AGENT; FERMENTICIN HV6B; LACTIC ACID; POLYPEPTIDE ANTIBIOTIC AGENT; SPERMICIDAL AGENT; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; FERMENTICIN HV6B, LACTOBACILLUS FERMENTUM;

ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTEROIDES; CANCER CELL; DOSE RESPONSE; DRUG ISOLATION; GARDNERELLA VAGINALIS; GROWTH INHIBITION; HUMAN; LACTOBACILLUS FERMENTUM; MOBILUNCUS; NONHUMAN; OPPORTUNISTIC INFECTION; SPERMATOZOON MOTILITY; STAPHYLOCOCCUS; VAGINA; ANIMAL; BACTERIUM; CELL DEATH; CELL LINE; CELL SHAPE; CHEMISTRY; CYTOLOGY; DNA FRAGMENTATION; DRUG EFFECT; DRUG SCREENING; GENETICS; HUMAN GENOME; ISOLATION AND PURIFICATION; MALE; MICROBIAL SENSITIVITY TEST; MOUSE; SPERMATOZOON; BACTERIA; DRUG EFFECTS;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; BACTERIOCINS; CELL DEATH; CELL LINE; CELL SHAPE; DNA FRAGMENTATION; DRUG SCREENING ASSAYS, ANTITUMOR; GENOME, HUMAN; HUMANS; LACTOBACILLUS FERMENTUM; MALE; MICE; MICROBIAL SENSITIVITY TESTS; SPERM MOTILITY; SPERMATOZOA;

EID: 84883186960     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/168438     Document Type: Article

References (41)

1. Madhivanan P., Krupp K., Hardin J., Karat C., Klausner J. D., Reingold A. L., Simple and inexpensive point-of-care tests improve diagnosis of vaginal infections in resource constrained settings. Tropical Medicine and International Health 2009 14 6 703 708 2-s2.0-67650954461 10.1111/j.1365-3156.2009.02274.x
2. Eschenbach D. A., History and review of bacterial vaginosis. American Journal of Obstetrics and Gynecology 1993 169 2 441 445 2-s2.0-0027296428
3. Mead P. B., Epidemiology of bacterial vaginosis. American Journal of Obstetrics and Gynecology 1993 169 2 446 449 2-s2.0-0027317092
4. Ling Z. D., Chang Q., Lipton J. W., Tong C. W., Landers T. M., Carvey P. M., Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain. Neuroscience 2004 124 3 619 628 2-s2.0-1342323484 10.1016/j.neuroscience.2003.12.017
5. Hay P. E., Morgan D. J., Ison C. A., Bhide S. A., Romney M., McKenzie P., Pearson J., Lamont R. F., Taylor-Robinson D., A longitudinal study of bacterial vaginosis during pregnancy. British Journal of Obstetrics and Gynaecology 1994 101 12 1048 1053 2-s2.0-0027970271
6. Moi H., Erkkola R., Jerve F., Nelleman G., Bymose B., Alaksen K., Tornqvist E., Should male consorts of women with bacterial vaginosis be treated? Genitourinary Medicine 1989 65 4 263 268 2-s2.0-0024421970
7. Lossick J. G., Treatment of sexually transmitted vaginosis/vaginitis. Reviews of Infectious Diseases 1990 12 supplement 6 S665 S681 2-s2.0-0025331180
8. Simons L. A., Amansec S. G., Conway P., Effect of Lactobacillus fermentum on serum lipids in subjects with elevated serum cholesterol. Nutrition, Metabolism and Cardiovascular Diseases 2006 16 8 531 535 2-s2.0-33751189183 10.1016/j.numecd.2005.10.009
9. Lauritano E. C., Gabrielli M., Scarpellini E., Ojetti V., Roccarina D., Villita A., Fiore F., Flore R., Santoliquido A., Tondi P., Gasbarrini G., Ghirlanda G., Gasbarrini A., Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. European Review for Medical and Pharmacological Sciences 2009 13 2 111 116 2-s2.0-65649154514
10. Barbés C., Boris S., Potential role of lactobacilli as prophylactic agents against genital pathogens. AIDS Patient Care and STDs 1999 13 12 747 751 2-s2.0-0033396530
11. Famularo G., Pieluigi M., Coccia R., Mastroiacovo P., De Simone C., Microecology, bacterial vaginosis and probiotics: perspectives for bacteriotherapy. Medical Hypotheses 2001 56 4 421 430 2-s2.0-0035030594 10.1054/mehy.2000.1195
12. Maggi L., Mastromarino P., Macchia S., Brigidi P., Pirovano F., Matteuzzi D., Conte U., Technological and biological evaluation of tablets containing different strains of lactobacilli for vaginal administration. European Journal of Pharmaceutics and Biopharmaceutics 2000 50 3 389 395 2-s2.0-0033790336 10.1016/S0939-6411(00)00121-1
13. Sutyak K. E., Anderson R. A., Dover S. E., Feathergill K. A., Aroutcheva A. A., Faro S., Chikindas M. L., Spermicidal activity of the safe natural antimicrobial peptide subtilosin. Infectious Diseases in Obstetrics and Gynecology 2008 2008 2-s2.0-54249143112 10.1155/2008/540758 540758
14. Kumar B., Balgir P. P., Kaur B., Mittu B., Garg N., Antimicrobial and spermicidal activity of native and recombinant pediocin CP2: a comparative evaluation. Archives of Clinical and Microbiology 2012 3 3
15. Blackburn P., Goldstein B. P., Applied microbiology. Inc. International Patent Application WO 97/10801, 1995
16. Howell T. H., Fiorellini J. P., Blackburn P., Projan S. J., De La Harpe J., Williams R. C., The effect of a mouthrinse based on nisin, a bacteriocin, on developing plaque and gingivitis in beagle dogs. Journal of Clinical Periodontology 1993 20 5 335 339 2-s2.0-0027181392
17. McConville P., SmithKline Beecham. Plc. International Patent Application WO 97: 06772, 1995
18. Peek R. M., Miller G. G., Tham K. T., Perez-Perez G. I., Zhao X., Atherton J. C., Blaser M. J., Heightened inflammatory response and cytokine expression in vivo to cag A+ Helicobacter pylori strains. Laboratory Investigation 1995 73 6 760 770 2-s2.0-0029561158
19. van Kraaij C., de Vos W. M., Siezen R. J., Kuipers O. P., Lantibiotics: biosynthesis, mode of action and applications. Natural Product Reports 1999 16 5 575 587 2-s2.0-0033213354 10.1039/a804531c
20. Farkas-Himsley H., Freedman J., Read S. E., Asad S., Kardish M., Bacterial proteins cytotoxic to HIV-1-infected cells. AIDS 1991 5 7 905 907 2-s2.0-0025915285
21. Kaur B., Balgir P. P., Mittu B., Chauhan A., Kumar B., Garg N., Isolation and In vitro characterization of anti- Gardnerella vaginalis bacteriocin producing Lactobacillus fermentum HV6b isolated from human vaginal ecosystem. Internatinal Journal of Fundamental and Applied Sciences 2012 1 3 41
22. Yang R., Johnson M. C., Ray B., Novel method to extract large amounts of bacteriocins from lactic acid bacteria. Applied and Environmental Microbiology 1992 58 10 3355 3359 2-s2.0-0026800644
23. Cintas L. M., Rodriguez J. M., Fernandez M. F., Sletten K., Nes I. F., Hernandez P. E., Holo H., Isolation and characterization of pediocin L50, a new bacteriocin from Pediococcus acidilactici with a broad inhibitory spectrum. Applied and Environmental Microbiology 1995 61 7 2643 2648 2-s2.0-0029016239
24. Pucci M. J., Vedamuthu E. R., Kunka B. S., Vandenbergh P. A., Inhibition of Listeria monocytogenes by using bacteriocin PA-1 produced by Pediococcus acidilactici PAC 1.0. Applied and Environmental Microbiology 1988 54 10 2349 2353 2-s2.0-0023812186
25. Wilson R. D., Fricke P. M., Leibfried-Rutledge M. L., Rutledge J. J., Penfield C. M. S., Weigel K. A., In vitro production of bovine embryos using sex-sorted sperm. Theriogenology 2006 65 6 1007 1015 2-s2.0-33644695362 10.1016/j.theriogenology.2005.07.007
26. Katla T., Naterstad K., Vancanneyt M., Swings J., Axelsson L., Differences in susceptibility of Listeria monocytogenes strains to sakacin P, sakacin A, pediocin PA-1, and nisin. Applied and Environmental Microbiology 2003 69 8 4431 4437 2-s2.0-0042029595 10.1128/AEM.69.8.4431-4437.2003
27. Kumar B., Balgir P. P., Kaur B., Mittu B., Chauhan A., In Vitro cytotoxicity of native and rec-pediocin CP2 against cancer cell lines: a comparative study. Pharmaceutical Analytical Acta 2012 3 183
28. Thirabunyanon M., Biotherapy for and protection against gastrointestinal pathogenic infections via action of probiotic bacteria. Maejo International Journal of Science and Technology 2011 5 1 108 128 2-s2.0-79953063150
29. Lohans C. T., Vederas J. C., Development of class IIa bacteriocins as therapeutic agents. International Journal of Microbiology 2012 2012 13 2-s2.0-84855577092 10.1155/2012/386410 386410
30. Todorov S. D., Botes M., Danova S. T., Dicks L. M. T., Probiotic properties of Lactococcus lactis ssp. lactis HV219, isolated from human vaginal secretions. Journal of Applied Microbiology 2007 103 3 629 639 2-s2.0-34547872715 10.1111/j.1365-2672.2007.03290.x
31. Ridgway E. J., Brown J. M., Listeria monocytogenes meningitis in the acquired immune deficiency syndrome-limitations of conventional typing methods in tracing a foodborne source. Journal of Infection 1989 19 2 167 171 2-s2.0-0024415561
32. Boris S., Barbés C., Role played by lactobacilli in controlling the population of vaginal pathogens. Microbes and Infection 2000 2 5 543 546 2-s2.0-0034044398 10.1016/S1286-4579(00)00313-0
33. Joerger R. D., Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poultry Science 2003 82 4 640 647 2-s2.0-0043163537
34. Reddy K. V. R., Aranha C., Gupta S. M., Yedery R. D., Evaluation of antimicrobial peptide nisin as a safe vaginal contraceptive agent in rabbits: in vitro and in vivo studies. Reproduction 2004 128 1 117 126 2-s2.0-4043124620
35. Vogt C., Untersuchungen Uber Die Entwicklungsgeschichte Der Geburtshelferkroete (Alytes Obstetricians) 1842 Solothurn, Switzerland Jent & Gassman
36. Farkas-Himsley H., Cheung R., Bacterial proteinaceous products (Bacteriocins) as cytotoxic agents of neoplasia. Cancer Research 1976 36 10 3561 3567 2-s2.0-0017146746
37. Jayawardene A., Farkas-Himsley H., Vibriocin: a Bacteriocin from Vibrio comma II. Interaction with sensitive bacteria. MicroBios 1969 4 325
38. Nomura M., Colicins and related bacteriocins. Annual Review of Microbiology 1967 21 257 284 2-s2.0-0014047739
39. Plant L., Conway P., Association of Lactobacillus spp. with Peyer's patches in mice. Clinical and Diagnostic Laboratory Immunology 2001 8 2 320 324 2-s2.0-0035108475 10.1128/CDLI.8.2.320-324.2001
40. Plant L. J., Conway P. L., Adjuvant properties and colonization potential of adhering and non-adhering Lactobacillus spp. following oral administration to mice. FEMS Immunology and Medical Microbiology 2002 34 2 105 111 2-s2.0-0037063983 10.1016/S0928-8244(02)00343-7
41. Kang S., Conway P. L., Characteristics of the adhesion of PCC® Lactobacillus fermentum VRI 003 to Peyer's patches. FEMS Microbiology Letters 2006 261 1 19 24 2-s2.0-33745712470 10.1111/j.1574-6968.2006.00315.x